Picture of H Lundbeck A/S logo

HLUN A H Lundbeck A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Brief: H. Lundbeck Announces Positive Results From RESOLUTION Trial

Dec 3 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * EFFICACY OF VYEPTI HIGHLIGHTED BY NEW CLINICAL TRIAL
RESULTS IN
SEVERE MIGRAINE
    * - VYEPTI MET PRIMARY ENDPOINT, SHOWING STATISTICALLY
SIGNIFICANT
GREATER MONTHLY MIGRAINE DAY (MMD) REDUCTIONS

Source text:  ID:nWkr6NsSCk 
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on H Lundbeck A/S

See all news